News › Industry News, News

Law Firm Announces It Is Investigating Evolus on Behalf of Evolus Stockholders

September 9, 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Evolus, Inc. on behalf of Evolus stockholders. Its investigation concerns whether Evolus has violated the federal securities laws and/or engaged in other unlawful business practices.
Evolus is a California-based medical aesthetics company. The company and its South Korean partner, Daewoong Pharmaceutical Co., developed Jeuveau, a competitor to Allergan’s Botox. Jeuveau has recently become a strong, more affordable competitor of Botox.
Read more at GlobeNewswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
    • Galderma Receives EU Approval for Restylane Shaype: Bone-Mimicking Hyaluronic Acid Injectable for Chin
    • Merz Aesthetics’ Ultherapy PRIME Gains FDA Clearance for Knee Skin Laxity
    • USA Payments Becomes Gold Vendor Affiliate with the American Med Spa Association
    • CVS, Eli Lilly Expand Consumer Access to GLP-1 Weight Loss Medications
Advertisement